{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:34:54Z","timestamp":1786736094692,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijd.ijd_344_18","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T01:35:27Z","timestamp":1578879327000},"page":"33","source":"Crossref","is-referenced-by-count":22,"title":["Antimelanocyte antibodies: A possible role in patients with vitiligo"],"prefix":"10.4103","volume":"65","author":[{"given":"MohammadA","family":"Gaballah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MahaA","family":"El-Gayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ManalE","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EmanR","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MoustafaA","family":"Elsaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.275765-1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: A comprehensive overview part I.Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.275765-2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.275765-3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: Focus on clinical aspects, immunopathogenesis, and therapy","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"key-10.4103\/0019-5154.275765-4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.EWX.0000450307.76457.a3","article-title":"Vitiligo: A review of the pathogenesis","author":"Choi","year":"2014","journal-title":"J Egypt Womens Dermatol Soc","ISSN":"https:\/\/id.crossref.org\/issn\/1687-1537","issn-type":"print"},{"key":"key-10.4103\/0019-5154.275765-5","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","author":"Jin","year":"2016","journal-title":"Nat Genet"},{"key":"key-10.4103\/0019-5154.275765-6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mehy.2010.10.034","article-title":"Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity","author":"Lin","year":"2011","journal-title":"Med Hypotheses"},{"key":"key-10.4103\/0019-5154.275765-7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.275765-8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1468-3083.2005.01295.x","article-title":"Assessment of the immune system in 55 Iranian patients with vitiligo","author":"Farrokhi","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.275765-9","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","article-title":"Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo","author":"Kroon","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.275765-10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.EWX.0000497014.08992.a2","article-title":"Emerging treatments for vitiligo: Gaining insight from pathogenesis","author":"Refat","year":"2017","journal-title":"J Egypt Womens Dermatol Soc","ISSN":"https:\/\/id.crossref.org\/issn\/1687-1537","issn-type":"print"},{"key":"key-10.4103\/0019-5154.275765-11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12369","article-title":"Cellular stress and innate inflammation in organ-specific autoimmunity: Lessons learned from vitiligo","author":"Harris","year":"2016","journal-title":"Immunol Rev"},{"key":"key-10.4103\/0019-5154.275765-12","first-page":"240","article-title":"Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: A multicenter Italian study","author":"Ingordo","year":"2014","journal-title":"Dermatology"},{"key":"key-10.4103\/0019-5154.275765-13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0019-5154.275765-14","first-page":"677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: The vitiligo area scoring index","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.275765-15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/0019-5154.275765-16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/etm.2016.3949","article-title":"Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo","author":"Zhu","year":"2017","journal-title":"Exp Ther Med"},{"key":"key-10.4103\/0019-5154.275765-17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11318020-000000000-00000","article-title":"Childhood vitiligo in China: Clinical profiles and immunological findings in 620 cases","author":"Lin","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0019-5154.275765-18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"key-10.4103\/0019-5154.275765-19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.1985.tb01532.x","article-title":"The significance of vitiligo antibodies","author":"Bystryn","year":"1985","journal-title":"J Dermatol"},{"key":"key-10.4103\/0019-5154.275765-20","first-page":"1085","article-title":"Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients","author":"Zailaie","year":"2005","journal-title":"Saudi Med J"},{"key":"key-10.4103\/0019-5154.275765-21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/mmr.2016.5354","article-title":"Hydroxychloroquine protects melanocytes from autoantibody-induced injury by reducing the binding of antigen-antibody complexes","author":"Li","year":"2016","journal-title":"Mol Med Rep"},{"key":"key-10.4103\/0019-5154.275765-22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.275765-23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12476636","article-title":"Cytolytic antibodies to melanocytes in vitiligo","author":"Cui","year":"1993","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.275765-24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","author":"Cui","year":"1995","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.275765-25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.275765-26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2010.01181.x","article-title":"Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo","author":"Kemp","year":"2011","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0019-5154.275765-27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","author":"Rezaei","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.275765-28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","article-title":"Apoptosis of melanocytes in vitiligo results from antibody penetration","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"J Autoimmun"},{"key":"key-10.4103\/0019-5154.275765-29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0923-1811(95)00427-0","article-title":"Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients","author":"Park","year":"1996","journal-title":"J Dermatol Sci"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:15Z","timestamp":1786732635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_344_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["275765"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_344_18","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}